Repository logo
 

Dutch, UK and US professionals' perceptions of screening for Barrett's esophagus and esophageal adenocarcinoma: a concept mapping study.

Published version
Peer-reviewed

Repository DOI


Change log

Authors

Sijben, Jasmijn 
Rainey, Linda 
Peters, Yonne 
Fitzgerald, Rebecca C 
Wani, Sachin 

Abstract

BACKGROUND: Novel, less-invasive technologies to screen for Barrett's esophagus (BE) may enable a paradigm shift in early detection strategies for esophageal adenocarcinoma (EAC). Understanding professionals' perspectives on screening is important to determine how to proceed. We aimed to explore and compare professionals' perceptions of screening for BE and EAC screening in three countries. METHODS: In this study, 29 Dutch, 20 British and 18 American health care professionals (clinicians, researchers and policy makers) participated in concept mapping: a mixed-methods consensus building methodology. Statements on perceived barriers, facilitators, advantages, disadvantages, implications or worries associated with screening for BE and EAC were collected in asynchronous digital brainstorm sessions. Subsequently, participants sorted the statements into groups according to thematic similarity and assessed the relevance of each statement in evaluating the acceptability of BE and EAC screening. Multidimensional scaling and cluster analysis were used to map the associations between generated statements. RESULTS: Professionals across three countries identified eight consistent themes that relate to their perceptions of screening for BE and EAC: (1) Benefits, (2) Harms, (3) Clinical effectiveness concerns, (4) Screening population, (5) Screening modality, (6) Resources, (7) Ownership, and (8) Public communication. Dutch and American professionals prioritized the potential health benefits of screening but also questioned clinical impact. In contrast, British participants prioritized identification of the screening population and suitable test. CONCLUSIONS: Most professionals see potential in less-invasive screening tests for BE and EAC but underline the need to define the target screening population and determine benefits and harms before widely employing them. Successful implementation will require thoughtful consideration of the involvement of general practitioners, readiness of endoscopy and pathology services, balanced public communication, and country-specific regulations.

Description

Acknowledgements: The authors thank Henk Schers, Breg Braak, Irene Debiram, and Nicola Grehan for their assistance with the data collection process. The authors also thank Izhar Bagwan, Corinne Bakker, Bertine Bast, Ian Beales, Dorien van der Biessen-van Beek, Duncan Blake, Truuske de Bock, Jan Bornschein, Geert Bulte, David Chan, Parakrama Chandrasoma, Marion Claes, Helen Coleman, Scott Corbett, Tom Crosby, Katherine Dickerman, Jason Dunn, Gary Falk, Kieran Foley, Vicky Goh, James Gossage, John Haydek, Yasmijn van Herwaarden, Remco Huiszoon, Madhu Iyengar, Marnix Jansen, Blake Jones, Jeffrey Kaplan, David Katzka, Sunnie Kim, Bastiaan Klarenbeek, Iris Lansdorp-Vogelaar, Alexis Leal, Christopher Lieu, Arjan Lock, Mirjam van Loon, Martin McCarter, Elizabeth Montgomery, Iris Nagtegaal, Grard Nieuwenhuizen, Gert Olthuis, Ariadne Ooms, Frank Oort, Claire Palles, Christopher Peters, Frans Peters, Massimiliano Di Pietro, Chella van der Post, Leo van Rossum, Heidi Rutten, Maartje Schermers, Erik Schoon, Pim Schout, Ruud Schrauwen, Iris Seriese, Siddharth Singh, Jo Skinner, Richard Skipworth, Marije van Slingerland, Manon Spaander, Adriaan Tan, Danielle Timmermans, Jamie Weaver, David Weinberg, Ravy Vajravelu, Rena Yadlapati, Yeng Ang, and anonymous participants for their thoughtful and diligent participation throughout the study period. All respondents participated independently from their affiliation.

Keywords

Barrett’s esophagus, Early cancer diagnosis, Esophageal adenocarcinoma, Physician’s practice patterns, Screening, Humans, Barrett Esophagus, Esophageal Neoplasms, Adenocarcinoma, United Kingdom

Journal Title

BMC Cancer

Conference Name

Journal ISSN

1471-2407
1471-2407

Volume Title

23

Publisher

Springer Science and Business Media LLC
Sponsorship
MRC (MR/W014122/1)